Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer

BACKGROUND: Signaling pathways that converge on two different transcription factor complexes, NFκB and AP-1, have been identified in estrogen receptor (ER)-positive breast cancers resistant to the antiestrogen, tamoxifen. METHODS: Two cell line models of tamoxifen-resistant ER-positive breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yamei, Yau, Christina, Gray, Joe W, Chew, Karen, Dairkee, Shanaz H, Moore, Dan H, Eppenberger, Urs, Eppenberger-Castori, Serenella, Benz, Christopher C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852565/
https://www.ncbi.nlm.nih.gov/pubmed/17407600
http://dx.doi.org/10.1186/1471-2407-7-59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852565/
https://www.ncbi.nlm.nih.gov/pubmed/17407600
http://dx.doi.org/10.1186/1471-2407-7-59

Ejemplares similares